BlackRock Amends Cencora Stake, Maintains Passive Investment
Ticker: COR · Form: SC 13G/A · Filed: Jan 24, 2024 · CIK: 1140859
| Field | Detail |
|---|---|
| Company | Cencora, INC. (COR) |
| Form Type | SC 13G/A |
| Filed Date | Jan 24, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**BlackRock updated its Cencora stake, still a big passive holder.**
AI Summary
BlackRock Inc. has updated its ownership stake in Cencora, Inc. (formerly AmerisourceBergen Corp.) as of December 31, 2023, filing an Amendment No. 15 to its Schedule 13G. This filing indicates BlackRock's passive investment in the pharmaceutical wholesaler, confirming its continued significant, though non-controlling, interest. For investors, this means a major institutional player maintains a substantial position, which can signal confidence in Cencora's long-term prospects, but also highlights that BlackRock is not seeking to influence management.
Why It Matters
This filing shows that BlackRock, a massive institutional investor, continues to hold a significant, but passive, stake in Cencora, Inc., signaling its ongoing confidence in the company without seeking control.
Risk Assessment
Risk Level: low — This is a routine update from a passive institutional investor and does not indicate any immediate risk or change in company control.
Analyst Insight
Investors should note that a major institutional investor like BlackRock maintains a significant, passive stake in Cencora, Inc., which can be seen as a vote of confidence in the company's stability, but does not suggest any impending activist changes or takeovers.
Key Players & Entities
- BlackRock Inc. (company) — the reporting person and institutional investor
- Cencora, Inc. (company) — the subject company, formerly AmerisourceBergen Corp.
- December 31, 2023 (date) — the date of the event requiring the filing
- Amendment No. 15 (number) — the specific amendment number to the Schedule 13G filing
- 03073E105 (number) — the CUSIP number for Cencora, Inc. Common Stock
Forward-Looking Statements
- BlackRock will maintain a passive investment strategy in Cencora, Inc. (BlackRock Inc.) — high confidence, target: 2024-12-31
- Cencora, Inc. will continue its operations in wholesale drugs, proprietaries, and druggists' sundries. (Cencora, Inc.) — high confidence, target: 2025-01-24
FAQ
What type of filing is this document?
This document is an SC 13G/A, specifically Amendment No. 15, filed under Rule 13d-1(b) of the Securities Exchange Act of 1934.
Who is the subject company of this filing?
The subject company is Cencora, Inc., which was formerly known as AmerisourceBergen Corp. until its name change on May 17, 2001.
Who is the entity making this filing?
The entity making this filing is BlackRock Inc., a security broker, dealer, and flotation company based in New York, NY.
What is the CUSIP number for the securities mentioned in this filing?
The CUSIP number for the Common Stock of Cencora, Inc. is 03073E105.
What is the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' is December 31, 2023.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 24, 2024 regarding Cencora, Inc. (COR).